RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH
Recruiting
N/A
Interventional Study
Basal Ganglia Hemorrhage
Intraventricular Hemorrhage
Brainstem Stroke
Intracranial Hemorrhage, Spontaneous
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,000 (estimated)
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intracerebral hemorrhage (ICH) is one of the most devastating forms of stroke, with high rates of death and disability worldwide. Despite advances in medical and surgical care, effective therapeutic options remain limited. To address this gap, the RAINBOW-ICH trial has been designed as a nationwide, multicenter, randomized umbrella trial evaluating the efficacy and safety of AI-assisted, robotic-g…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Umbrella Trial Inclusion Criteria:
1. Age ≥18 years；
2. Clinical diagnosis of spontaneous hemorrhagic stroke；
Umbrella Trial Exclusion Criteria:
1\. Radiologically diagnosed cerebrovascular abnormalities, as well as ischemic infarction converting to intracerebral hemorrhage, or recent (within 1 y…
Contacts